skip to main content
Centre for Health Economics and Policy Analysis

News

Seminar will look at shifting views of public and patient involvement in Canadian drug assessment

22 Jan 2019

Research into shifting opinions about the legitimacy of scientific evidence and public participation when it comes to recommendations about what drugs the government should list for public drug coverage will be presented on Wednesday Feb. 27 by Katherine Boothe at CHEPA’s next seminar.

Boothe is an associate professor in McMaster’s department of political science and a member of CHEPA.  In her seminar, entitled “Public and patient involvement in Canadian drug assessment: practitioner and participant views,” she will report on research in progress that investigates shifting ideas about legitimacy as they relate to scientific evidence and public participation in drug listing recommendations.

The seminar will examine how the adoption of measures for public and patient involvement since 2006 have affected understandings of legitimacy on Canadian drug advisory committees, focusing on the views of technical committee members.

Boothe's research draws from interviews with members of three Canadian drug assessment committees as well as evidence of participants’ early views contained in reports by consultants and a parliamentary committee to analyze views related to legitimacy. It finds some important tensions between democratic conceptions of legitimacy that are linked to the inclusiveness of the policy process and which drive public and patient involvement, and moral-scientific conceptions of legitimacy that are linked to objectivity and specific norms of scientific evidence.

She says that future research anticipates analyzing the views of lay members of drug advisory committees and participants outside of the committees, particularly members of patient communities.

Boothe holds a PhD from the University of British Columbia. She studies comparative public policy in advanced industrial democracies, with a focus on health and social policy. She has previously written on the development of public pharmaceutical insurance programs in Canada, Australia, and the UK.

The seminar will be held on Wednesday Feb 27 from 12:30 to 1:30 p.m. in CRL-B119. All are welcome to attend.

It will also be available remotely online through WebEx. To join, please copy and paste the link below into your browser. The password is: CHEPAseminar

https://mcmaster.webex.com/mcmaster/j.php?MTID=m94bec1a167b177a0d523e8cdcee2dbf7

Please send questions, comments or suggestions to the Webmaster (chepa@mcmaster.ca ).
Please review our Copyright Disclaimer policy

Interactive Marketing | Cubicle Fugitive